Akebia Therapeutics AKBA
NASDAQ AKBA
$0.92 +0.03 (+3.83%)
At close: Sep 30, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) EV to CFO (2016 - 2026)

Updated

Akebia Therapeutics' EV to CFO came in at 3.71 for Q2 2026, up 6.8% from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) EV to CFO (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Akebia Therapeutics reported EV to CFO of -8.66; for FY2025, it came in at 3.57.

  • The five-year range for quarterly EV to CFO is 3.47 (Q1 2026) to 17.21 (Q3 2025).
  • Business Quant data shows AKBA's EV to CFO at 3.47 (Q1 2026), 3.57 (Q4 2025) and 17.21 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Akebia Therapeutics 241.85 Mn -427.63 Mn 38.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.71
Mar 31, 2026 3.47
Dec 31, 2025 3.57
Sep 30, 2025 17.21
Sep 30, 2017 10.73
Jun 30, 2017 3.52
Mar 31, 2017 3.41
Dec 31, 2016 2.45
API Access

Akebia Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=AKBA&period=max&api_key=YOUR_API_KEY